ASBP
Financials
- Market Capitalization 11.94 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.aspirebiolabs.com
- Headquarter Cayman Islands
- FIGI BBG015STV133
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4713 |  MBRX Moleculin Biotech, Inc. - Common Stock | 0.65 USD | -5.80% | +8.33% | -51.13% | -79.37% | 12.66 M USD | ||
| 4724 |  QNRX Quoin Pharmaceuticals Ltd - American Depositary Shares | 6.12 USD | +18.60% | +13.33% | +45.37% | -34.33% | 12.29 M USD | ||
| 4734 |  SNTI Senti Biosciences, Inc. - Common Stock | 0.38 USD | 0.00% | 0.00% | +5.56% | -60.08% | 11.84 M USD | ||
| 4740 |  PDSB PDS Biotechnology Corporation - Common Stock | 0.21 USD | -4.55% | -4.55% | -68.66% | -82.79% | 11.75 M USD |
Frequently asked questions about Aspire Biopharma Holdings, Inc. Common Stock
What is the Aspire Biopharma Holdings, Inc. Common Stock stock price today?
The current price of Aspire Biopharma Holdings, Inc. Common Stock (ASBP) is 8.51. Over the past 24 hours, the stock has changed by +2.65%. Follow the ASBP chart for real-time price dynamics.
What is the stock ticker of Aspire Biopharma Holdings, Inc. Common Stock?
Aspire Biopharma Holdings, Inc. Common Stock trades under the ticker ASBP. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Aspire Biopharma Holdings, Inc. Common Stock stock going up?
ASBP has changed by +7.72% over the last week, +43.27% over the last month, and +445.51% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Aspire Biopharma Holdings, Inc. Common Stock?
Aspire Biopharma Holdings, Inc. Common Stock currently has a market capitalization of 11.94 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does Aspire Biopharma Holdings, Inc. Common Stock release financial reports?
Yes. You can track Aspire Biopharma Holdings, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were Aspire Biopharma Holdings, Inc. Common Stock earnings last quarter?
Last quarter, Aspire Biopharma Holdings, Inc. Common Stock reported earnings of -1.22 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Aspire Biopharma Holdings, Inc. Common Stock revenue for the last quarter?
Aspire Biopharma Holdings, Inc. Common Stock reported quarterly revenue of 63.1 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Aspire Biopharma Holdings, Inc. Common Stock net income for the last quarter?
Aspire Biopharma Holdings, Inc. Common Stock reported net income of -1.27 M for the last quarter. The previous quarter showed -3.22 M, which means net income changed by +60.65%.
What is Aspire Biopharma Holdings, Inc. Common Stock EBITDA?
Aspire Biopharma Holdings, Inc. Common Stock EBITDA is -2.64 M, and its EBITDA margin is -4 176.99%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Aspire Biopharma Holdings, Inc. Common Stock stock?
You can buy Aspire Biopharma Holdings, Inc. Common Stock (ASBP) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Aspire Biopharma Holdings, Inc. Common Stock stock?
Investing in Aspire Biopharma Holdings, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ASBP chart and related analysis on metatrader.com as part of your research.